Investment firm Morgans has provided insights into three major Australian companies—Amcor, ANZ Group Holdings Ltd, and Macquarie Group Ltd—offering recommendations on whether to buy, hold, or sell their shares. With a focus on fundamentals and market performance, these evaluations could guide investors looking to adjust their portfolios.
Amcor: Strong Buy Recommendation
Morgans analysts have issued a strong buy rating for Amcor (ASX: AMC), suggesting that the packaging giant may currently be undervalued. The broker has set a price target of $15.20 per share, emphasizing the company’s low trading multiples, positive growth prospects, and attractive dividend yield.
Following a solid first quarter performance for fiscal year 2026, Morgans notes that management has become increasingly confident about achieving synergy targets for the year. The firm stated, “Our target price is maintained at $15.20 and with a 12-month forecast total shareholder return of 25%, we upgrade our rating to BUY from ACCUMULATE.” The anticipated catalysts for positive performance include upcoming quarterly results that may exceed expectations and successful asset sales.
ANZ: Caution Advised
In contrast, Morgans has adopted a cautious stance towards ANZ Group Holdings Ltd (ASX: ANZ), maintaining a trim rating, which falls between hold and sell. The broker has set a price target of $33.09 after the bank’s second-half results failed to meet market expectations.
The analysis revealed a 7% decline in profit compared to the first half of 2025, alongside a significant increase in credit impairment charges. Morgans explained, “Excluding $1.1 billion of significant items, 2H25 profit declined, with a -3% drop in pre-provision profit.” The rating reflects concerns over the current share price, which is considered high relative to historical valuations, prompting the recommendation to trim holdings during periods of share price strength.
Macquarie: Hold Amid Fair Valuation
Regarding Macquarie Group Ltd (ASX: MQG), Morgans has assigned a hold rating with a revised price target of $215.00. The investment bank’s first half performance for fiscal year 2026 showed a net profit after tax of A$1.65 billion, which was a modest 3% increase year-on-year but fell 9% short of market consensus expectations.
Morgans highlighted that while certain factors contributed to the earnings miss—such as increased investment spending and impairments—the overall guidance for the full year remains stable. The firm noted, “We make mild downgrades to our MQG FY26 earnings of -2%, with future year earnings slightly lifted by 2% to 4%.” The updated price target reflects a moderate adjustment, as the stock trades at a price-to-earnings ratio of 19x, which Morgans considers fair value.
In summary, investors interested in blue-chip stocks should consider Morgans’ recommendations. The firm’s assessments of Amcor, ANZ, and Macquarie provide a snapshot of current market conditions and company performance, aiding in informed investment decisions.
For those contemplating investments, it is essential to weigh these insights against broader market trends and individual financial goals.
